Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.
Jørn HerrstedtY SummersK JordanJ von PawelA H JakobsenM EwertzS ChanJ D NaikM KarthausS DubeyR DavisG M FoxPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
NCT01857232.